Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v2.4.0.8
Consolidated Statements of Operations (USD $)
12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Revenues    
Products $ 6,346,050 $ 7,453,222
Services 9,503,819 7,800,750
Total revenues 15,849,869 15,253,972
Cost of sales    
Products 4,709,767 5,290,535
Services 6,109,974 4,098,363
Total cost of sales 10,819,741 9,388,898
Gross profit 5,030,128 5,865,074
Operating expenses    
General and administrative 7,018,133 6,643,120
Selling 1,423,587 1,225,580
Aborted public offering costs 258,512 0
Total operating expenses 8,700,232 7,868,700
Loss from operations (3,670,104) (2,003,626)
Other income (expense)    
Interest and other income 3,958 48,397
Interest expense (141,065) (71,208)
Total other income (expense) (137,107) (22,811)
Loss before income taxes (3,807,211) (2,026,437)
Consolidated net loss (3,807,211) (2,026,437)
Less: Loss attributable to the noncontrolling interest 357,722 389,480
Net loss attributable to Tecogen Inc. $ (3,449,489) $ (1,636,957)
Net loss per share - basic and diluted (usd per share) $ (0.26) $ (0.12)
Weighted average shares outstanding - basic and diluted (shares) 13,385,155 13,135,071